Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 20, 2023
0Patent Application Number
166670560
Date Filed
October 29, 2019
0Patent Citations
Patent Primary Examiner
CPC Code
Monoclonal antibodies that bind and inhibit activation of epidermal growth factor receptor related member ErbB3/HER3 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of ErbB3/HER3.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
